PUBLISHER: Allied Market Research | PRODUCT CODE: 1513324
PUBLISHER: Allied Market Research | PRODUCT CODE: 1513324
The pharmaceutical packaging market was valued at $111.7 billion in 2023 and is estimated to reach $233.3 billion by 2035, exhibiting a CAGR of 6.3% from 2024 to 2035. Pharmaceutical packaging encompasses the design, production, and utilization of containers, closures, and other materials intended to house and protect pharmaceutical products throughout their lifecycle, from manufacturing to patient use. It serves multiple functions, including ensuring product stability, integrity, and safety, while also facilitating accurate dosing, labeling, and information dissemination. Pharmaceutical packaging must comply with stringent regulatory requirements to guarantee product quality and patient safety. It encompasses a wide range of materials, such as plastics, glass, metals, and specialized polymers, each chosen for its compatibility with the medication and its ability to maintain product efficacy. Effective pharmaceutical packaging plays a crucial role in safeguarding public health by preserving medication potency and preventing contamination or tampering.The pharmaceutical industry is witnessing a surge in the adoption of smart packaging solutions aimed at enhancing patient engagement and product identification. Companies are increasingly incorporating technologies such as smart labeling with RFID and NFC tags to track products, engage with patients, and ensure medication adherence. Additionally, 2D barcodes and RFID tags are being utilized to monitor packages and pallets across the supply chain. NFC tags have emerged as a cutting-edge solution for medication adherence, enabling direct communication with consumers. Child-resistant primary and secondary packaging is evolving with smarter features, including Ziplock bags and pouches for enhanced safety and compliance. Furthermore, advancements in 3D visualization and printing techniques are streamlining packaging design processes, reducing waste, and driving growth in pharmaceutical packaging. This trend highlights an increasing focus on utilizing technology to enhance patient outcomes and optimize supply chain operations within the pharmaceutical packaging industry.The pharmaceutical packaging market is segmented into product, material type, and region. By product, the market is classified into parenteral containers, plastic bottles, blister packaging, closures, specialty bags, labels, and others. On the basis of material type, the market is fragmented into glass, aluminum foils, plastics and polymers, paper and paperboards, and others. Region-wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, North Africa, Middle East & Africa).The key players that operate in the pharmaceutical packaging market are Amcor Plc., Aptar Group, Inc., Catalent Inc., CCL Industries Inc., Becton, Dickinson and Company, Gerresheimer AG, West Pharmaceutical Services, Inc., Nipro Corporation, Berry Global Group, Inc and SCHOTT pharmaceutical packaging. The key players have adopted product launch, product development, collaboration, partnership and product approval as the key strategies to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are: